TY - JOUR
T1 - Distinct regulation of gene expression by prostaglandin F2α (PGF2α) is associated with PGF2α resistance or susceptibility in human granulosa-luteal cells
AU - Tsai, Shaw Jenq
AU - Wu, Meng Hsing
AU - Chuang, Pei Chin
AU - Chen, Hsiu Mei
N1 - Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2001/5
Y1 - 2001/5
N2 - The effects of human chorionic gonadotrophin (HCG) and prostaglandin F2α (PGF2α) on regulation of human granulosa-luteal cell (GLC) function at different stages of differentiation (day 2 versus day 8 of culture) were studied. Expression of LH receptor mRNA and biosynthesis of progesterone were HCG dependent in human GLC at all stages (n=6,P < 0.05). Steady-state concentrations of mRNA encoding for FP (a specific high-affinity plasma membrane receptor for PGF2α) were not dependent on, but were stimulated by, addition of HCG (10 IU/ ml) or 8-bromo-cAMP (0.5 mmol/l) (n=6, P < 0.05). Treatment with PGF2α (100 nmol/l) decreased FP mRNA concentration, but had no effect on LH receptor and cyclo oxygenase-2 (COX-2) expression on day 2 of cultured GLC (n = 8). As a result, the progesterone biosynthesis by GLC was not affected. On day 8, PGF2α induced FP and PGHS-2 expression and at the same time decreased LH receptor expression, resulting in inhibition of progesterone output by GLC. Our data demonstrated that early stage GLC (day 2 of culture) are resistant to PGF2α-induced inhibition of progesterone synthesis but underwent further differentiation and acquired luteolytic capacity after 8 days culture in vitro. We conclude that, via distinct gene regulation at different stages of differentiation, human GLC may become resistant or susceptible to PGF2α-induced luteolysis.
AB - The effects of human chorionic gonadotrophin (HCG) and prostaglandin F2α (PGF2α) on regulation of human granulosa-luteal cell (GLC) function at different stages of differentiation (day 2 versus day 8 of culture) were studied. Expression of LH receptor mRNA and biosynthesis of progesterone were HCG dependent in human GLC at all stages (n=6,P < 0.05). Steady-state concentrations of mRNA encoding for FP (a specific high-affinity plasma membrane receptor for PGF2α) were not dependent on, but were stimulated by, addition of HCG (10 IU/ ml) or 8-bromo-cAMP (0.5 mmol/l) (n=6, P < 0.05). Treatment with PGF2α (100 nmol/l) decreased FP mRNA concentration, but had no effect on LH receptor and cyclo oxygenase-2 (COX-2) expression on day 2 of cultured GLC (n = 8). As a result, the progesterone biosynthesis by GLC was not affected. On day 8, PGF2α induced FP and PGHS-2 expression and at the same time decreased LH receptor expression, resulting in inhibition of progesterone output by GLC. Our data demonstrated that early stage GLC (day 2 of culture) are resistant to PGF2α-induced inhibition of progesterone synthesis but underwent further differentiation and acquired luteolytic capacity after 8 days culture in vitro. We conclude that, via distinct gene regulation at different stages of differentiation, human GLC may become resistant or susceptible to PGF2α-induced luteolysis.
UR - http://www.scopus.com/inward/record.url?scp=0035002609&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035002609&partnerID=8YFLogxK
U2 - 10.1093/molehr/7.5.415
DO - 10.1093/molehr/7.5.415
M3 - Article
C2 - 11331663
AN - SCOPUS:0035002609
SN - 1360-9947
VL - 7
SP - 415
EP - 423
JO - Molecular Human Reproduction
JF - Molecular Human Reproduction
IS - 5
ER -